Optiray 350 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast media used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during imaging studies. Ideal for both intra-arterial and intravenous use, it is manufactured by Liebel-Flarsheim Company LLC.

Optiray 350 741 mg/mL is primarily used as a contrast agent in medical imaging to improve the visibility of internal structures. It is commonly administered during procedures like angiography and computed tomography (CT) scans. This contrast media helps healthcare professionals obtain clearer images, aiding in the diagnosis and evaluation of various conditions. Optiray 350 is designed for both intra-arterial and intravenous use, making it versatile for different diagnostic needs.

When administered, Optiray 350 741 mg/mL may cause a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or a brief feeling of warmth. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Optiray 350 741 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the product. Always follow the guidelines provided by healthcare professionals for safe and effective use.

Optiray 350 741 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to consult with a healthcare provider before use if you are taking other medications. Alcohol and certain substances can also influence the body's response to contrast media, so it is important to discuss all current treatments with your healthcare provider.